Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late

Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Gilead Sciences and Bristol-Myers Squibb urged A california judge that is federal to nix direct purchasers’ claims alleging the pharmaceutical businesses involved in anti-competitive conduct to block generic competition and keep HIV medicine rates artificially high, arguing the matches must be delivered to arbitration or […]